Please login to the form below
A new era for patient services?
How COVID-19 is changing the landscape for industry interaction with patients across countries
Why pharma should invest in the education of doctors
By Tim Russell, Heather Hancock and Deepak Jadon
Weirdos and misfits
Can diversity improve engagement in healthcare?
Growing up as a patient is hard to manage
By Clare Moloney
We’ll need more than a spoonful of sugar to counter vaccine hesitancy
By Satinder Phull
-
Rare diseases: redefining medical communicationsBy Ian Keary
-
The dawn of a new era in medical educationBy Annlouise Pendse
-
The power of high-value, highly relevant content to support clinical decisionsby Sandrine Veillet
-
A new era in European Parliament: policymakers need to hear from pharma by Nick Hoile
-
Transitions in healthcareBy Dr Jonathan Reston
-
Evolving behaviour changeBy Paul Tanner
COVID-19 Updates and Daily News
Featured jobs
- AZ’s COVID-19 vaccine trial to continue after Brazilian volunteer death
- FDA sets November date for expert panel review of Biogen’s aducanumab
- Pfizer CEO pushes back COVID-19 vaccine submission to November
- Novartis scores CHMP backing for cholesterol drug Leqvio
- GSK chief exec ‘optimistic’ COVID-19 vaccine could be available next year
- Roche and Prothena set to advance Parkinson’s disease candidate into phase 2b
- Eliminating pharmaceutical rebates, is this déjà vu?
- Bayer pays an initial $2bn for gene therapy firm AskBio
- Both AZ and J&J set to resume US COVID-19 vaccine trials
- AZ’s COVID-19 vaccine shows promise in younger and older adults
- Bayer's drop of the future
- Patients are ready to embrace decentralised clinical trials, are you?
PMHub
Graphite Digital
Graphite is a digital agency which partners with globally respected healthcare organisations to create powerful digital experiences. We help our...
Latest intelligence
- Eliminating pharmaceutical rebates, is this déjà vu?
- By Andrew Parece and Matthew Majewski...
- Patients are ready to embrace decentralised clinical trials, are you?
- Traditional clinical trial designs simply can’t withstand the impact of COVID-19. While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid...
- Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
- The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
Quick links
Infographics
